<DOC>
	<DOCNO>NCT01050374</DOCNO>
	<brief_summary>This randomise , control , double-blinded clinical study investigate safety efficacy MBD combination PZQ treatment SCH STH child age 1-15 year age .</brief_summary>
	<brief_title>Safety Efficacy Drug Combinations Against Schistosomiasis</brief_title>
	<detailed_description />
	<mesh_term>Parasitic Diseases</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<mesh_term>Mebendazole</mesh_term>
	<mesh_term>Piperazine</mesh_term>
	<mesh_term>Piperazine citrate</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>Those age 115 year age Are infect schistosomiasis soiltransmitted helminthiasis Whose parent consent willing participate Those acute chronic disease schistosomiasis soiltransmitted helminthiasis Those history serious adverse drug reaction</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>